Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D

Viral Immunology

Volumn 16, Issue 3, 2003, Pages 307-320

  Zhang, Yunfei ^a   Smith, Patrick M ^a   Frampton, Arthur R ^a,b   Osterrieder, Nikolaus ^c   Jennings, Stephen R ^a   O'Callaghan, Dennis J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; EQUINE HERPES VIRUS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; SPLEEN; VIRUS INFECTION;

ANIMALIA; DNA VIRUSES; EQUIDAE; EQUINE HERPESVIRUS 1; HERPESVIRIDAE;

EID: 0141960082     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403322396118     Document Type: Article

References (56)

1. Allen, G.P., and J.T. Bryans. 1986. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog. Vet. Microbiol. Immunol. 2:78-144.
2. Awan, A.R., Y.C. Chong, and H.J. Field. 1990. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71:1131-1140.
3. Alwan, W.H., W.J. Kozlowska, and P.J. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
4. Alwan, W.H., and P.J. Openshaw. 1993. Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11:431-437.
5. Blacklaws, B.A., S. Krishna, A.C. Minson, and A.A. Nash. 1990. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727-736.
6. Bowles, D.E., V.R. Holden, Y. Zhao, and D.J. O'Callaghan. 1997. The ICP0 protein of equine herpesvirus 1 is an early protein that independently transactivates expression of all classes of viral promoters. J. Virol. 71:4904-4914.
7. Bürki, F., W. Rossmanith, N. Nowotny, et al. 1990. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Q. 12:80-86.
8. Burrows, R., D. Goodridge, and M.S. Denyer. 1984. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus. Vet. Rec. 114:369-374.
9. Carroll, C.L., and H.A. Westbury. 1985. Isolation of equine herpesvirus 1 from the brain of a horse affected with paresis. Aust. Vet. J. 62:345-346.
10. Coffman, R.L., B. Shrader, J. Carty, et al. 1987. A mouse T cell product that preferentially enhances IgA production. I. Biologic characterization. J. Immunol. 139:3685-3690.
11. Colle, C.F., C.C. Flowers, and D.J. O'Callaghan. 1992. Open reading frames encoding a protein kinase, homolog of glycoprotein gX of pseudorabies virus, and a novel glycoprotein map within the unique short segment of equine herpesvirus type 1. Virology 188:545-557.
12. Colle, C.F., and D.J. O'Callaghan. 1995. Transcriptional analyses of the unique short segment of EHV-1 strain Kentucky A. Virus Genes 9:257-268.
13. Colle, C.F., E.B. Tarbet, W.D. Grafton, et al. 1996. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL. Virus Res. 43:111-124.
14. Csellner, H., C. Walker, J.E. Wellington, et al. 2000. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Arch. Virol. 145:2371-2385.
15. Czerkinsky, C.C., L.A. Nilsson, H. Nygren, et al. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
16. Flowers, C.C., S.P. Flowers, Y. Sheng, et al. 1995. Expression of membrane-bound and secreted forms of equine herpesvirus 1 glycoprotein D by recombinant baculovirus. Virus Res. 35:17-34.
17. Flowers, C.C., and D.J. O'Callaghan. 1992. The equine herpesvirus type 1 (EHV-1) homolog of herpes simplex virus type 1 US9 and the nature of a major deletion within the unique short segment of the EHV-1 KyA strain genome. Virology 190:307-15.
18. Frampton, A.R., P.M. Smith, Y. Zhang, et al. 2002. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model. Virus Res. 90:287-301.
19. Graham, B.S., G.S. Henderson, Y.W. Tang, et al. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
20. Guo, P.X., S. Goebel, M.E. Perkus, et al. 1990. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity. J. Virol. 64:2399-2406.
21. Hahon, N., J.A. Booth, and J.D. Stewart. 1979. Aflatoxin inhibition of viral interferon induction. Antimicrob. Agents Chemother. 16:277-282.
22. Hannant, D., D.M. Jessett, T. O'Neill, et al. 1993. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res. Vet. Sci. 54:299-305.
23. Horton, J., J.E. Hotchin, K.B. Olson, and J.N. Davies. 1971. The effects of MP virus infection in lymphoma. Cancer Res. 31:1066-1068.
24. Jackson, T.A., B.I. Osburn, D.R. Cordy, and J.W. Kendrick. 1977. Equine herpesvirus 1 infection of horses: studies on the experimentally induced neurologic disease. Am. J. Vet. Res. 38:709-719.
25. Kishimoto, T., and T. Hirano. 1988. Molecular regulation of B lymphocyte response. Annu. Rev. Immunol. 6:485-512.
26. Kohl, S. 1992. The role of antibody in herpes simplex virus infection in humans. Curr. Top. Microbiol. Immunol. 179:75-78.
27. Krishna, S., B.A. Blacklaws, H.A. Overton, et al. 1989. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. J. Gen. Virol. 70:1805-1814.
28. Matsumura, T., T. Kondo, S. Sugita, et al. 1998. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Virology 242:68-79.
29. Matsumura, T., D.J. O'Callaghan, T. Kondo, and M. Kamada. 1996. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. Vet. Microbiol. 48:353-365.
30. McGhee, J.R., J. Mestecky, C.O. Elson, and H. Kiyono. 1989. Regulation of IgA synthesis and immune response by T cells and interleukins. J. Clin. Immunol. 9:175-199.
31. Mo, X.Y., S.R. Sarawar, and P.C. Doherty. 1995. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 69:1288-1291.
32. O'Callaghan, D.J., and N. Osterrieder, 1999. Equine herpesviruses, pp. 508-515. In: R. Webster and A. Granoff (eds.), Encyclopedia of Virology, 2nd ed. Academic Press/Harcourt Brace, San Diego.
33. alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72:4756-4764.
34. Onions, D. 1991. Equine herpesvirus: new approaches to an old problem. Equine Vet. J. 23:6-7.
35. Osterrieder, N., V.R. Holden, C. Brandmuller, et al. 1996. The equine herpesvirus 1 IR6 protein is nonessential for virus growth in vitro and modified by serial virus passage in cell culture. Virology 217:442-451.
36. Osterrieder, N., A. Neubauer, C. Brandmüller, et al. 1996. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence. Virology 226:243-251.
37. Osterrieder, N., R. Wagner, C. Brandmüller, et al. 1995. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208:500-510.
38. Paul, W.E. 1987. Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions. FASEB J. 1:456-461.
39. Perdue, M.L., M.C. Kemp, C.C. Randall, and D.J. O'Callaghan. 1974. Studies of the molecular anatomy of the LM cell strain of equine herpes virus type 1: proteins of the nucleocapsid and intact virion. Virology 59:201-216.
40. Ruitenberg, K.M., J.R. Gilkerson, J.E. Wellington, et al. 2001. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease. Virus Res. 79:125-135.
41. Ruitenberg, K.M., D.N. Love, J.R. Gilkerson, et al. 2000. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody. Vet. Microbiol. 76:117-127.
42. Ruitenberg, K.M., C. Walker, D.N. Love, et al. 2000. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18:1367-1373.
43. Sedgwick, J.D., and P.G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301-309.
44. Simmons, A., and A.A. Nash. 1985. Role of antibody in primary and recurrent herpes simplex infections. J. Virol. 53:944-948.
45. Smith, P.M., Y. Zhang, W.D. Grafton, et al. 2000. Severe murine lung immunopathology elicited by the pathogenic equine herpesvirus 1 strain RacL11 correlates with early production of macrophage inflammatory proteins 1α, 1β, and 2 and tumor necrosis factor-alpha. J. Virol. 74:10034-10040.
46. Smith, P.M., Y. Zhang, S.R. Jennings, and D.J. O'Callaghan. 1998. Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice. J. Virol. 72:5366-5372.
47. Snapper, C.M., C. Peschel, and W.E. Paul. 1988. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140:2121-2127.
48. Stokes, A., D.G. Alber, R.S. Cameron, et al. 1996. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. Virus Res. 44:97-109.
49. Stokes, A., G.P. Allen, L.A. Pullen, and P.K. Murray. 1989. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. J. Gen. Virol. 70:1173-1183.
50. Stokes, A., R.S. Cameron, R.N. Marshall, and R.A. Killington. 1997. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model. Virus Res. 50:159-173.
51. Tewari, D., S.V. Nair, M.C. De Ungria, et al. 1995. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Arch. Virol. 140:789-797.
52. Tewari, D., J.M. Whalley, D.N. Love, and H.J. Field. 1994. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75:1735-1741.
53. Whittaker, G.R., L.A. Taylor, D.M. Elton, et al. 1992. Glycoprotein 60 of equine herpesvirus type 1 is a homologue of herpes simplex virus glycoprotein D and plays a major role in penetration of cells. J. Gen. Virol. 173:801-809.
54. Yalamanchili, R.R., and D.J. O'Callaghan. 1990. Sequence and organization of the genomic termini of equine herpesvirus type 1. Virus Res. 15:149-161.
55. Zhang, Y., P.M. Smith, S.R. Jennings, and D.J. O'Callaghan. 2000. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D. Virology 268:482-492.
56. Zhang, Y., P.M. Smith, E.B. Tarbet, et al. 1998. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD. Virus Res. 56:11-24.